This new regional public health resource was announced by the regional president during the 2024 Debate on the State of the Region. Work on adapting Pavilion 1 of the Valdebebas health complex is expected to last six months, with the aim of the center becoming operational by early 2027.

The future Neurorehabilitation Center will have the capacity to treat 1,123 people annually, offering 216 places and 596 daily therapies. It will provide assistance to adult and pediatric patients with brain and spinal cord injuries through Physiotherapy, Speech Therapy, Occupational Therapy, and other associated specialties, with a multidisciplinary approach tailored to each user's specific needs. Additionally, the resource will operate under a day care model that will encourage the participation of families and caregivers.

The Enfermera Isabel Zendal Hospital is already a reference thanks to the Specialized Day Care Center for people with Amyotrophic Lateral Sclerosis (CEADELA), which began operating in April 2024. The regional Executive is also working on incorporating an Experimental Institute of Neurotechnology for Brain Health into the Zendal. This new resource will enable Madrid's public health system to advance in improving the brain health of its citizens and strengthen research into neurodegenerative diseases such as dementia, Parkinson's, and Alzheimer's, becoming a strategic complex for the development of new lines of study and treatment.

To facilitate scientific progress, the regional Government will equip Pavilion 3 of this public Hospital with cutting-edge devices for research and medical diagnosis of neurodegenerative pathologies. This will include state-of-the-art machinery, such as very high-field magnetic resonance imaging to optimize the analysis and early detection of these diseases. Its implementation, along with the incorporation of biomedical engineering and Artificial Intelligence, will improve patient care.